December 1, 2014
Saladax Biomedical Announces U.S. Launch of MyImatinib™ Chemotherapy Exposure Optimization Test
Commercial Launch of MyImatinib™ Test Expands MyCare™ portfolio of Chemotherapy Exposure Optimization tests available from…
